377 related articles for article (PubMed ID: 12915048)
1. Novel anti-inflammatory therapy for Parkinson's disease.
Gao HM; Liu B; Zhang W; Hong JS
Trends Pharmacol Sci; 2003 Aug; 24(8):395-401. PubMed ID: 12915048
[TBL] [Abstract][Full Text] [Related]
2. Glatiramer acetate could be a potential therapeutic agent for Parkinson's disease through its neuroprotective and anti-inflammatory effects.
Tsai SJ
Med Hypotheses; 2007; 69(6):1219-21. PubMed ID: 17548170
[TBL] [Abstract][Full Text] [Related]
3. 3-hydroxymorphinan is neurotrophic to dopaminergic neurons and is also neuroprotective against LPS-induced neurotoxicity.
Zhang W; Qin L; Wang T; Wei SJ; Gao HM; Liu J; Wilson B; Liu B; Zhang W; Kim HC; Hong JS
FASEB J; 2005 Mar; 19(3):395-7. PubMed ID: 15596482
[TBL] [Abstract][Full Text] [Related]
4. Neurodegeneration and inflammation in Parkinson's disease.
Phani S; Loike JD; Przedborski S
Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S207-9. PubMed ID: 22166436
[TBL] [Abstract][Full Text] [Related]
5. Neuroinflammation and the prospects for anti-inflammatory treatment of Parkinson's disease.
Whitton PS
Curr Opin Investig Drugs; 2010 Jul; 11(7):788-94. PubMed ID: 20571974
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory properties rather than anti-oxidant capability is the major mechanism of neuroprotection by sodium salicylate in a chronic rotenone model of Parkinson's disease.
Thakur P; Nehru B
Neuroscience; 2013 Feb; 231():420-31. PubMed ID: 23159314
[TBL] [Abstract][Full Text] [Related]
7. Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair.
Vivekanantham S; Shah S; Dewji R; Dewji A; Khatri C; Ologunde R
Int J Neurosci; 2015; 125(10):717-25. PubMed ID: 25364880
[TBL] [Abstract][Full Text] [Related]
8. Role of inflammation in the pathogenesis of Parkinson's disease: models, mechanisms, and therapeutic interventions.
Hong JS
Ann N Y Acad Sci; 2005 Aug; 1053():151-2. PubMed ID: 16179518
[No Abstract] [Full Text] [Related]
9. Neuroinflammation in Parkinson's disease.
Hirsch EC; Vyas S; Hunot S
Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S210-2. PubMed ID: 22166438
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease.
Kurkowska-Jastrzebska I; Litwin T; Joniec I; Ciesielska A; Przybyłkowski A; Członkowski A; Członkowska A
Int Immunopharmacol; 2004 Oct; 4(10-11):1307-18. PubMed ID: 15313429
[TBL] [Abstract][Full Text] [Related]
11. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?
Rogers J; Mastroeni D; Leonard B; Joyce J; Grover A
Int Rev Neurobiol; 2007; 82():235-46. PubMed ID: 17678964
[TBL] [Abstract][Full Text] [Related]
12. Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications.
Wilms H; Zecca L; Rosenstiel P; Sievers J; Deuschl G; Lucius R
Curr Pharm Des; 2007; 13(18):1925-8. PubMed ID: 17584117
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress and inflammation in Parkinson's disease: is there a causal link?
Hald A; Lotharius J
Exp Neurol; 2005 Jun; 193(2):279-90. PubMed ID: 15869932
[TBL] [Abstract][Full Text] [Related]
14. Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease.
Liu B; Dluzen DE
Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):555-65. PubMed ID: 17581209
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action.
Kim YJ; Park HJ; Lee G; Bang OY; Ahn YH; Joe E; Kim HO; Lee PH
Glia; 2009 Jan; 57(1):13-23. PubMed ID: 18661552
[TBL] [Abstract][Full Text] [Related]
16. The influence of microglia on the pathogenesis of Parkinson's disease.
Long-Smith CM; Sullivan AM; Nolan YM
Prog Neurobiol; 2009 Nov; 89(3):277-87. PubMed ID: 19686799
[TBL] [Abstract][Full Text] [Related]
17. Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Hirsch EC; Hunot S
Lancet Neurol; 2009 Apr; 8(4):382-97. PubMed ID: 19296921
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of animal models of Parkinson's disease for neuroprotective strategies.
Emborg ME
J Neurosci Methods; 2004 Oct; 139(2):121-43. PubMed ID: 15488225
[TBL] [Abstract][Full Text] [Related]
19. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease.
Lindsay RM; Altar CA; Cedarbaum JM; Hyman C; Wiegand SJ
Exp Neurol; 1993 Nov; 124(1):103-18. PubMed ID: 8282068
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models.
Hu LF; Lu M; Tiong CX; Dawe GS; Hu G; Bian JS
Aging Cell; 2010 Apr; 9(2):135-46. PubMed ID: 20041858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
